baber/WOPTO huggingface dataset:
Patent DE-602008006862-C5 (DE)
Inventor: KAAGMAN MATTHEUS
IPC: B29D30/46
Filed: 2008-02-29
Granted: 2020-06-25
Abstract: Cutting device for cutting a rubber component (9) for a green belt. The cutting device comprises a roller conveyor (1) for conveying the rubber component in a direction of conveyance. The roller conveyor comprises a number of conveyor rollers (2) which are substantially parallel to and spaced apart from each other. The cutting device comprises a knife (4) for cutting the rubber component at an angle with the direction of conveyance, wherein the cutting device is provided with a lifting beam (8) that extends transverse to the direction of conveyance between two conveyor rollers. The lifting beam (8) is vertically movable for lifting the rubber component. The knife (4) is arranged so as to be displaceable along a guide rail with respect to the roller conveyor, wherein the angle that the knife forms with the direction of conveyance is adjustable in a range of approximately 18° to approximately 34.
Patent RU-2681976-C9 (RU)
Inventor: FRUNTS Lukas
IPC: C04B28/02
Filed: 2014-04-07
Granted: 2019-08-26
Abstract: FIELD: chemistry. 
     SUBSTANCE: invention relates to the composition of a comb polymer, which is used to increase the flow rate and/or to reduce the viscosity of a mineral binder composition, where the comb polymer contains a main chain containing acidic groups and pendent chains attached to the main chain, wherein the average molecular weight (Μ n ) of all pendent chains range from 120 to 1,000 g/mol and the molar ratio of acid groups to the pendent chains is 0.8 to 1.6. Further, the pendent chains do not contain alkylene oxides with three or more hydrogen atoms. Also, the invention relates to self-compacting concrete and a molded product obtained by curing self-compacting concrete, which contains the above-mentioned comb polymer. Invention is developed in dependent claims of the invention. 
     EFFECT: proposed is the use of comb polymers to control the rheology of mineral binder compositions. 
     16 cl, 1 tbl
Patent RU-2756197-C9 (RU)
Title: Phenyl [a]indole [2,3-g] quinolysins, their preparation method, compositions containing them and application options
Inventor: LYU Khun
IPC: A61P3/04
Filed: 2017-03-29
Granted: 2022-03-14
Abstract: FIELD: pharmaceutics. 
     SUBSTANCE: invention relates to a condensed heterocyclic compound of the general formula (I) or its enantiomer, diastereomer, racemate and mixture thereof, where R 1  and R 2  are each independently selected from a group consisting of hydrogen, substituted or unsubstituted C1-C4 alkyl, substituted or unsubstituted C6-C10 aryl; and R 1  and R 2  are not both hydrogen or R 1  and R 2  and neighboring -(CH2)n-O and bound carbon atoms together form unsubstituted 5-element heterocyclic ring, wherein the specified heterocyclic ring is thiophene; each R 3 , R 4  is independently selected from a group consisting of hydrogen, substituted or unsubstituted C1-C6 alkyl, substituted or unsubstituted C6-C10 aryl, substituted or unsubstituted 5-element heterocyclic ring, which is selected from thiophene, furan and pyrrole, unsubstituted benzyl, -SO 2 R 9 ; R 5  is selected from a group consisting of hydrogen or halogen; R 6  and R 7  are each independently selected from a group consisting of hydrogen, unsubstituted C1-C2 alkyl, unsubstituted C1-C2 alkoxy, -OSO 2 R 9 ; R 8  is hydrogen; R 9  and R 10  are independently hydrogen, unsubstituted C1-C6 alkyl or unsubstituted C6 cycloalkyl, C6-C10 aryl unsubstituted or substituted with 1 halogen, benzyl; wherein, if both of R 3  and R 4  are hydrogen, then at least one of R 1 , R 2 , R 6 , R 7  is a group selected from a group consisting of substituted C6-C10 aryl; where “substituted” means that one, two or three hydrogen atoms in the group are substituted by a substituent selected from a group consisting of halogen, C1-C2 alkyl unsubstituted or substituted with three halogens, C1 alkoxy, hydroxy, cyano, unsubstituted 5-element heterocyclic ring selected from pyrazole, -NR 9 R 10 , -SO 2 R 9 , -OSO 2 R 9 , -COOR 9  and -OCOR 9 ; n is 1. The invention also relates to specific condensed heterocyclic compounds, a method for obtaining a compound of the formula (I) and a pharmaceutical composition based on a compound of the formula (I).  
     EFFECT: obtaining of a new condensed heterocyclic compounds useful for the treatment of metabolic diseases. 
     
       
     
     13 cl, 6 tbl, 414 ex
Patent DK-45190-D0 (DK)
Inventor: MONROY GLADYS H
IPC: C12N1/15
Filed: 1990-02-20
Abstract: The present invention provides recombinant polynucleotides which encode glucose oxidase (GO). It also provides recombinant expression systems which produce, and when desired, secrete active GO and GO analogs into the extracellular medium.
Patent DK-53786-D0 (DK)
Inventor: GROTENHUIS GERRIT
IPC: A61M5/34
Filed: 1986-02-04
Abstract: The invention relates to an injection syringe having an ampoule (11) in which a plunger (12) and a sealing stopper (17) are provided, and a needle holder (18) comprising a collar (21) to be provided on the ampoule in a sealing manner and a sleeve (20) dosed at its front end by means of a wall. Said end wall comprises on its outside a neck (19) for connecting an injection needle, an aperture (28) being recessed in the said front end of the sleeve. The side wall of the sleeve comprises at least one longitudinal duct (22) which, over a small part of its length, is in open communication with the room bounded by the inner walls of the sleeve.
Patent DK-60390-D0 (DK)
Inventor: JENSEN HANS-JUERGEN
IPC: E03C1/042
Filed: 1990-03-08
Abstract: In a device for fastening objects, in particular concealed connecting pieces for water fittings or pipes, wherein the object is held by means of one or more stud bolts (10) with the aid of nuts (121), it is proposed, for the purpose of adjustable fastening, that there be provided on the stud bolt(s) (10) in each case one adjusting nut (3) which reaches through a retaining opening (25) in the object from the rear with a projection in such a way that it can be turned from the front of the object, and that a lock nut (4) can be screwed on for fixing from the front. 
<IMAGE>
Patent DK-119991-D0 (DK)
Inventor: BALDRY MICHAEL GORDON CHARLES
IPC: A01K1/015
Filed: 1991-06-20
Abstract: PCT No. PCT/GB89/01525 Sec. 371 Date Jun. 12, 1991 Sec. 102(e) Date Jun. 12, 1991 PCT Filed Dec. 21, 1989 PCT Pub. No. WO90/07273 PCT Pub. Date Jul. 12, 1990.Small animal litter comprises an absorbent material containing an odor-reducing quantity of an aliphatic halo-nitro-bactericide such as those available under the Tradenames Bronopol, Bronidox or Myacide.
Patent DK-147588-D0 (DK)
Inventor: IIJIMA IKUO
IPC: C07D417/06
Filed: 1988-03-17
Abstract: Novel benzoxazine derivative of the formula: <CHEM> wherein R<1> is phenyl group or a substituted thiazolyl group; R<2> is hydrogen atom or a lower alkyl group; Q is single bond or a lower alkylene group, or a salt thereof are disclosed. Said derivative (I) and a salt thereof are useful as therapeutic agents for diabetes.
Patent DK-209090-D0 (DK)
Inventor: ESMON CHARLES T
IPC: C12P21/08
Filed: 1990-08-30
Abstract: A Ca<2+> dependent monoclonal antibody that specifically binds to a specific twelve peptide sequence (E D Q V D P R L I D G K) in the activation region of the protein C. The antibody does not bind to activated protein C and can be used to inhibit activation of protein C by thrombin-thrombomodulin. The antibody can be isolated from cell culture or ascites fluid in large quantities by affinity chromatography with mild conditions using the peptide bound to an immobilized substrate. The antibody has a number of specific uses in isolation and characterization of protein C and as a model for the design of Ca<2+> dependent antibodies for the isolation of other proteins, as a diagnostic, and as a therapeutic to prevent activation of protein C. The protein c can be naturally produced or produced by expression of the recombinant gene. Advantages of the antibody in purification of protein C include the specificity for protein C and not activated protein C, and the unique Ca<2+>-peptide binding specificity which allows the binding site to be protected when it is being immobilized on the chromatographic support. In vivo, the antibody has been demonstrated to inhibit tumor growth. The antibody can also be used to promote clotting in patients having high levels of Factor VIII inhibitors.
Patent DK-209989-D0 (DK)
Inventor: BIANCHI ANTONIO
IPC: B01J2/10
Filed: 1989-04-28
Abstract: A process for manufacturing a high bulk density particulate detergent composition, of a bulk density greater than 0.7 g/cc and preferably in the range of 0.8 to 1.0 g/cc, includes turbodrying a mixture of synthetic anionic organic detergent, preferably of sodium C12-13 linear alkylbenzene sulphonate, water, and fabric softening bentonite, in which turbodrying process the mixture is repeatedly subjected to centrifugal and axial forces which create thin films of the mixture, which are pulled apart, due to such forces, to form particles, which are further turbodried and thereby converted to high bulk density particles of substantially globular shape and desired particle sizes. In a preferred embodiment of the invention the mixture charged to the turbodryer is made by turbomixing an aqueous solution, dispersion or paste of anionic detergent with bentonite, and the mixture made thereby is directly turbodried. Also described are combined turbomixing and turbodrying apparatuses, and products of the invented processes.
Patent DK-375986-D0 (DK)
Inventor: WAKEFIELD BARRY ROGER
IPC: A22C13/00
Filed: 1986-08-06
Abstract: A machine for heat sealing the ends of shirred sausage casings comprises two carriages 19, 20 carried on rails 17, 18 a and movable by rams. 
<??>One carriage 19 carries arms 27, 28 which grip and twist one end 12 of sausage casing 13. Heat sealing means 55, 56 are provided and a shearing knife 60. 
<??>An inserter 39 inserts the heat sealed twist end back inside the shirred casing after it has been severed.
Patent DK-388587-D0 (DK)
Inventor: BERTHO ANNETTE
IPC: C11D1/83
Filed: 1987-07-24
Abstract: A clear, concentrated, pourable liquid detergent composition capable of being diluted with water to give a viscous dilute composition. This concentrated composition comprises at least one anionic surface agent, a viscosity regulator for the dilute composition, consisting of at least one surface agent chosen from the group made up of nonionic, amphoteric and zwitterionic surface agents, used in combination with at least one acid or its salt in such a quantity that it is dissolved in the concentrated composition, the surface agent and the acid or the salt being chosen so that the viscosity V2 of the dilute composition decreases, or increases and then decreases, when the quantity of acid or of its salt increases, in the case of given surface agents and water. 
<??>Application to compositions particularly for dishwashing. 
<IMAGE>
Patent DK-431784-D0 (DK)
Inventor: LEVITT BARRIE
IPC: C07D239/00
Filed: 1984-09-11
Abstract: There are disclosed novel oxopyrimidine derivatives of the general formulawherein R, and R<sub>2</sub> may be the same or different and are each hydrogen or lowel alkyl optionally substituted by lower alkoxy, and R<sub>3</sub> and R<sub>4</sub> may be the same or different and are each phenyl optionally substituted by lower alkyl or halogen, with the proviso that when R, and R<sub>2</sub> are both hydrogen, R<sub>3</sub> and R<sub>4</sub> are each substituted phenyl. Pharmaceutical compositions containing these compounds are described. The compounds of the invention are active anticonvulsant, antianxiety and muscle relaxant agents.
Patent DK-433886-D0 (DK)
Inventor: JONES BRIAN ELLWOOD
IPC: A61K9/60
Filed: 1986-09-10
Abstract: A hard gelatin capsule is filled with a chewable composition containing an ingredient for buccal absorption or having buccal activity.
Patent DK-453488-D0 (DK)
Inventor: CAMPBELL PATRICIA S
IPC: A61L15/16
Filed: 1988-08-12
Abstract: A method for preventing the formation of crystalline hydrates in a dispersion of a hydratable liquid in a nonaqueous matrix is disclosed. The method is particularly useful in the manufacture of laminated items formed from such dispersions and comprises forming individual subunits from such dispersions, heating the subunits, preferably after they have been packed in sealed containers, to a temperature high enough to melt the crystalline hydrate, maintaining said subunits at such temperature for a time sufficient to melt all the crystalline hydrate present and to prevent the occurrence of crystals for an extended period of time after cooling and cooling subunits to ambient conditions. The use of the method in the manufacture of transdermal delivery devices for the delivery of scopolamine base is described.
Patent DK-473087-D0 (DK)
Inventor: JAERVENKYLAE JYRI
IPC: B29C48/13
Filed: 1987-09-10
Abstract: This invention relates to an apparatus and a method for the production of outwardly ribbed, plastic pipes. The apparatus includes a core around which a plasticized material is pressed from a nozzle. A kernel having an essentially constant diameter is positioned at the terminal end of the core for a smooth inner face of the pipe. The outer face of the pipe is ribbed by grooves of axially displaceable chill moulds. The end zone of the kernel is provided for the cooling of the inner face of the pipe. In known apparatuses the grooves of the chill moulds are often filled incompletely and the inner face of the pipe becomes uneven on account of air bubbles, for instance. These disadvantages are avoided by heating an initial zone of the kernel for heating the inner face of the pipe and by shaping the surface of the initial zone to slightly expand conicallly in the production direction.
Patent NO-870384-D0 (NO)
Inventor: MUELLER RICHARD AUGUST
IPC: C07C323/20
Filed: 1987-01-30
Abstract: The compounds of the present invention comprise substituted phenolic thioethers represented by the formula:   <IMAGE> (I)  wherein: R1 and R2 are the same or different and independently represent tert-alkyl or phenyl; A represents methylene or methylene substituted by alkyl, dialkyl or hydroxy, provided that when A includes hydroxymethylene, the hydroxymethylene group is not adjacent to a heteroatom; B represents sulfur, sulfoxide, sulfone, oxygen, -NH- or nitrogen substituted by alkyl, phenyl, benzyl, substituted phenyl or substituted benzyl; C represents methylene or methylene substituted by alkyl; R3 represents CO2H, CO2-alkyl or a tetrazole group; m is 0 or 1, n is 2, 3 or 4 and p is 1, 2 or 3; and the pharmaceutically acceptable salts thereof. The compounds of the present invention are specific inhibitors of 5-lipoxygenase and, therefore, are useful in the treatment of local and systemic inflammation, allergy and hypersensitivity reactions and other disorders in which agents formed in the 5-lipoxygenase metabolic pathway are involved.
Patent NO-874692-D0 (NO)
Inventor: KAGECHI SHUNSAKU
IPC: C08K3/14
Filed: 1987-11-11
Abstract: An object of this invention is to provide fiber materials having properties such as selective absorption of solar energy effectively with a minimum loss of heat radiation which is useful for clothings such as sports and leisures or interior goods like curtain and the like or the outdoor leisure goods such as a tent and the like.
Patent NO-885104-D0 (NO)
Inventor: FLECKNOE-BROWN ANTHONY EARL
IPC: B29C48/355
Filed: 1988-11-16
Abstract: Hollow objects 14 can be formed by extruding a web 1 of thermoplastic material directly into a set of temperature controlled tempering rolls 2, 3 and 6, cooling upper and lower surface layers of the web by passage through the tempering rolls while maintaining the interior of the web in molten condition between said surface layers, feeding the partially cooled web 7 past a turning roll 8 onto a conveyor 10, and conveying the web to the entry of a thermoformer 15, the web 7 being allowed to remain on the conveyor 10 until the surface layer of the web which is in contact with the conveyor has been reheated by the molten interior of the web to a thermoformable temperature below that at which the web 7 will stick to the conveyor 10, the travel of the web 1 through the tempering rolls being controllable by adjusting the position of the tempering roll 6 to for example 6', and the travel of the web 7 on the conveyor being controllable by adjusting the position of the turning roll 8 to for example 8'.
Patent NO-903059-D0 (NO)
Inventor: WINTER GREGORY PAUL
IPC: C07K/
Filed: 1990-07-09
Abstract: The present invention relates to single domain ligands derived from molecules in the immunoglobulin (Ig) superfamily, receptors comprising at least one such ligand, methods for cloning, amplifying and expressing DNA sequences encoding such ligands, preferably using the polymerase chain reaction, methods for the use of said DNA sequences in the production of Ig-type molecules and said ligands or receptors, and the use of said ligands or receptors in therapy, diagnosis or catalysis.
Patent NO-920129-D0 (NO)
Inventor: LAEMMERMANN FRITZ
IPC: A23K40/10
Filed: 1992-01-09
Abstract: Batch process for preparing concentrated choline chloride on a natural carrier, a natural carrier being circulated and predried in a closed system of apparatus, comprising a mixer, pneumatic drier, separator, blower, transport means and the associated piping and instrumentation, the delivery of the choline chloride solution in the mixer and simultaneously the drying in the pneumatic drier being carried out during the circulation and after the predrying of the natural carrier. <IMAGE>
Patent NO-924347-D0 (NO)
Inventor: SKUBALLA WERNER
IPC: C07C/
Filed: 1992-11-11
Abstract: The invention discloses new leukotriene B4 derivatives of formula (I), wherein R?1 stands for CH2?OH, CH3?, CF3?, COOR?5, CONR?6R?7, or R?1 together with R?2 stands for a carbonyl group, R?2 and R?3 are the same or different and stand for H or an organic acid residue containing 1 to 15 carbon atoms, R?4 stands for H, C1?-C10? alkyl, possibly substituted one or more times by chlorine or bromine, C3?-C10? cycloalkyl, a C6?-C10? aryl residue possibly substituted one or more times by chlorine, bromine or phenyl, C1?-C4? alkyl, C1?-C4? alkoxy, fluoromethyl, chloromethyl, trifluoromethyl, carboxy or hydroxy, or a 5- or 6-membered aromatic heterocyclic ring with at least one heteroatom, R?5 stands for hydrogen, C1?-C10? alkyl, C3?-C10? cycloalkyl, a C6?-C10? aryl residue possibly substituted one to three times by chlorine, bromine or phenyl, C1?-C4? alkyl, C1?-C4? alkoxy, fluoromethyl, chloromethyl, trifluoromethyl, carboxy or hydroxy, CH2?-CO-(C6?-C10?) aryl or a 5- or 6-membered ring with at least one heteroatom, A stands for a trans,trans-CH=CH-CH=CH, a -CH2?CH2?-CH=CH- or a tetramethylene group, B stands for a C1?-C10? straight-chain or branched-chain alkylene group, possibly substituted by fluorine, or the group of formula (a), D stands for a direct bond, oxygen, sulphur, -C=C-, -CH=CR8? or, together with B, for a direct bond, R6? and R7? are the same or different and stand for H or C1?-C4? alkyl or R7? stands for H and R6? stands for C1?-C10? alkanoyl or C1?-C10? alkanesulphonyl, R8? stands for H, C1?-C5? alkyl, chlorine or bromine, n is equal to 3 to 5 and, when R5? stands for hydrogen, their salts with physiologically tolerable bases and their cyclodextrin clathrates.
Patent NO-932502-D0 (NO)
Inventor: NOESSNER GERHARD
IPC: A61P31/10
Filed: 1993-07-08
Abstract: Novel phospholipid derivatives, preparation processes therefor and their use as medicaments are described.
Patent NO-951327-D0 (NO)
Inventor: BISSERY MARIE-CHRISTINE
IPC: A61K33/243
Filed: 1995-04-05
Abstract: Combinations of (a) taxol, taxotere, or their derivatives, with (b) a therapeutic substance are used in the treatment of neoplastic disorders. Pref., (b) is an alkylating agent, (esp. cyclophosphamide, ifosamide, melphalan, hexamethyl melamine, thiotepa, and dacarbazine), an anti-metabolite, (esp. 5-fluorouracil, cytarabin, methotrexate, idatrexate, and trimetrexate), a fusel poison (esp. a vinca alkaloid, their synthetic and semi-synthetic analogues, estramustine, and taxoids), an epidophyllotoxin, (esp. etoposide or teniposide), an antibiotic, esp. daunorubicin, doxorubicin, bleomycin, or mitomycin), an enzyme (esp. L-asparaginase), a topoisomerase inhibitor, (esp. camptothecin, CPT-11, topotecan, and pyridobenzoindole derivatives), procarbazine, mitoxantrone, platinum coordination complexes (esp. cisplatin and carboplatin), biological response modifiers and growth inhibitors, (esp. interferons and interleukins), and haematopoietic growth factors. The taxane derivative (a) may comprise 10-90% of the active materials.
Patent NO-953887-D0 (NO)
Inventor: WIKLUND ERNST SIGURD GUSTAF FO
IPC: B23B45/14
Filed: 1995-09-29
Abstract: PCT No. PCT/SE94/00286 Sec. 371 Date Sep. 29, 1995 Sec. 102(e) Date Sep. 29, 1995 PCT Filed Mar. 29, 1994 PCT Pub. No. WO94/22624 PCT Pub. Date Oct. 13, 1994Method of direction control consisting in producing one or more parallel reference lines (7,8) that may be manipulated in such a way that their directions become parallel to the intended direction and with the help of plane mirrors making images (9,10) of the reference lines and images (12,13) of the object the straightening up of which is to be controlled. Implement for use at the method.
Patent NO-955119-D0 (NO)
Inventor: OLSEN JOHN ELMERDAHL
IPC: C12Q1/689
Filed: 1995-12-15
Abstract: PCT No. PCT/GB94/01316 Sec. 371 Date Mar. 11, 1996 Sec. 102(e) Date Mar. 11, 1996 PCT Filed Jun. 17, 1994 PCT Pub. No. WO95/00664 PCT Pub. Date Jan. 5, 1995The invention provides nucleic acid molecules for the detection and identification of Salmonella species, methods for detecting one or more Salmonella serotpes using the nucleic acid molecules of the invention as probes or primers in DNA-based detection systems and kits for carrying out the invention.
Patent NO-960527-D0 (NO)
Inventor: TUBEL PAULO S
IPC: E21B47/06
Filed: 1996-02-09
Abstract: A system adapted for controlling and/or monitoring a plurality of production wells from a remote location is provided. This system is capable of controlling and/or monitoring: (1) a plurality of zones in a single production well; (2) a plurality of zones/wells in a single location (e.g., a single platform); or (3) a plurality of zones/wells located at a plurality of locations (e.g., multiple platforms). The multizone and/or multiwell control system of this invention is composed of multiple downhole electronically controlled electromechanical devices and multiple computer based surface systems operated from multiple locations. Important functions for these systems include the ability to predict the future flow profile of multiple wells and to monitor and control the fluid or gas flow from either the formation into the wellbore, or from the wellbore to the surface. The control system of this invention is also capable of receiving and transmitting data from multiple remote locations such as inside the borehole, to or from other platforms, or from a location away from any well site.
Patent NO-972608-D0 (NO)
Inventor: NEW ROGER RANDAL CHARLES
IPC: A61K9/127
Filed: 1997-06-06
Abstract: The invention provides a process for the preparation of a single phase hyudrophobic preparation comprising a hydrophilic species in a hydrophobic solvent wherein a compound which is: (a) a low molecular weight compound having at least some degree of polarity; and/or (b) a lipid-soluble organic acid; and/or (c) an amphiphile; and (d) glycerol or other polyhydric alcohols; is added during the process to aid solubilisation.